ticagrelor

Generic: ticagrelor

Labeler: changzhou pharmaceutical factory
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ticagrelor
Generic Name ticagrelor
Labeler changzhou pharmaceutical factory
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 90 mg/1

Manufacturer
Changzhou Pharmaceutical Factory

Identifiers & Regulatory

Product NDC 55488-0543
Product ID 55488-0543_79364f10-afa0-4a5f-96d2-f82bcc9cf928
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216187
Listing Expiration 2026-12-31
Marketing Start 2025-10-28

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 554880543
Hyphenated Format 55488-0543

Supplemental Identifiers

RxCUI
1116635 1666332
UPC
0369452508305 0369452509302 0369452509173 0369452508176
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ticagrelor (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number ANDA216187 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 90 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (55488-0543-1)
  • 500 TABLET in 1 BOTTLE (55488-0543-2)
source: ndc

Packages (2)

55488-0543-1 60 TABLET in 1 BOTTLE (55488-0543-1) 55488-0543-2 500 TABLET in 1 BOTTLE (55488-0543-2)

Ingredients (1)

ticagrelor (90 mg/1)

Linked Drug Pages (1)

Ticagrelor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "79364f10-afa0-4a5f-96d2-f82bcc9cf928", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0369452508305", "0369452509302", "0369452509173", "0369452508176"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["751410c1-452b-400b-a640-d31623a6fda3"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Changzhou Pharmaceutical Factory"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (55488-0543-1)", "package_ndc": "55488-0543-1", "marketing_start_date": "20251028"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (55488-0543-2)", "package_ndc": "55488-0543-2", "marketing_start_date": "20251028"}], "brand_name": "Ticagrelor", "product_id": "55488-0543_79364f10-afa0-4a5f-96d2-f82bcc9cf928", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "55488-0543", "generic_name": "Ticagrelor", "labeler_name": "Changzhou Pharmaceutical Factory", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA216187", "marketing_category": "ANDA", "marketing_start_date": "20251028", "listing_expiration_date": "20261231"}